This content was archived on June 19 2014.
Information identified as archived on the Web is for reference, research or recordkeeping purposes. It has not been altered or updated after the date of archiving. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats on the "Contact Us" page.
The Marihuana Medical Access Program (the Program) provides seriously ill Canadians with reasonable and legal access to marihuana for medical purposes.
In response to concerns heard from Canadians, the Government of Canada announced on June 17, 2011 that it is considering improvements to the Program. The proposed improvements would reduce the risk of abuse and exploitation by criminal elements and keep our children and communities safe.
The news release announcing the proposed improvements to the Program is available at: Government of Canada Considers Improvements to the Marihuana Medical Access Program to Reduce the Risk of Abuse and Keep our Children and Communities Safe.
Health Canada would like to hear from Canadians about the improvements under consideration. Interested Canadians will have an opportunity to comment on the proposed improvements starting June 17, 2011. The comment period will close on July 31, 2011.
Interested Canadians are invited to provide feedback on a short discussion document by clicking on the link below titled "Consultation Document". Comments may be submitted, in English or French, by using the Feedback Form below, or by email, fax, or mail.
Please note, during the Canada Post strike, Health Canada would like to remind its clients to use alternative means, such as a licensed courier, email, or fax to submit comments to the Department.
Comments received during this consultation process will be considered carefully as Health Canada moves forward with this initiative. Comments will only be accepted until July 31, 2011.
Health Canada will publish a summary of input received during this consultation process.
If you have any questions, contact us at email@example.com.